A European and a Canadian multicenter randomized, double-blind trial of the sirolimus-eluting stent (SES) in patients with de novo native coronary artery lesions (NEW-SIRIUS):: 4-year clinical outcomes

被引：0
|
作者：
Schampaert, Erick
Schofer, Joachim
Breithardt, Gunter
Cohen, Eric A.
Schluter, Michael
Wichter, Thomas
机构：
[1] Hop Sacre Coeur Montreal, Ctr Cardiovasc, Montreal, PQ H4J 1C5, Canada
[2] Univ Hamburg, Hamburg, Germany
[3] Univ Hosp Munster, Munster, Germany
[4] Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON, Canada
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2006年 / 98卷 / 8A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：156M / 156M
页数：1
相关论文
共 50 条
  • [1] A European and Canadian multicenter randomized, double-blind trial of the Sirolimus-Eluting Stent (SES) in patients with de novo native coronary artery lesions (NEW-SIRIUS):: 5-year clinical outcomes
    Schampaert, Eric
    Schofer, Joachim
    Breithardt, Guenther
    Cohen, Eric A.
    Schlueter, Michael
    Wichter, Thomas
    Wittelbols, Kristel
    Stoll, Hans-Peter
    CIRCULATION, 2007, 116 (16) : 466 - 466
  • [2] The european multicenter, randomized, double-blind study of the sirolimus-eluting stent in the treatment of patients with de novo coronary artery lesions (E-SIRIUS): 4-year clinical outcomes
    Schofer, J.
    Breithardt, G.
    Garcia, E.
    Gershlick, A.
    Schlueter, M.
    Wichter, T.
    Wijns, W.
    EUROPEAN HEART JOURNAL, 2006, 27 : 829 - 829
  • [3] The European multicenter, randomized, double-blind study of the Sirolimus-eluting Stent in the treatment of patients with de novo coronary artery lesions: 5-year clinical outcomes of the E-SIRIUS TRIAL
    Kelbaek, Henning
    Schampoert, Erick
    Simon, Ruediger
    Rubino, Paolo
    Legrand, Victor
    Guagliumi, Giulio
    Reimers, Bernard
    Taeymans, Yves
    Van den Branden, Frank
    Wittebols, Kristel
    Stoll, Hans-Peter
    Breithardt, Guenther
    Schofer, Joachim
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (8A): : 35L - 35L
  • [4] The European Multicenter, randomized, double-blind study of the sirolimus-eluting stent in the treatment of patients with De Novo Coronary Artery Lesions (E-SIRIUS): 5-Year Clinical Outcomes
    Kelbaek, H.
    Simon, R.
    Rubino, P.
    Legrand, V.
    Guagliumi, G.
    Reimers, B.
    Taeymans, I.
    Van den Branden, F.
    Breithardt, G.
    Schofer, J.
    EUROPEAN HEART JOURNAL, 2007, 28 : 329 - 329
  • [5] The European multicenter, randomised, double-blind study of the sirolimus-eluting stent in the treatment of patients with de novo coronary artery lesions (E-SIRIUS): 3-year clinical outcomes
    Legrand, V.
    Schofer, J.
    Taeymans, Y.
    Reimers, B.
    van den Branden, F.
    Breithardt, G.
    Gershlick, H.
    Wijns, W.
    EUROPEAN HEART JOURNAL, 2005, 26 : 313 - 313
  • [6] The European multicentre, randomized, double-blind study of the sirolimus-eluting stent in the treatment of patients with de novo coronary artery lesions (E-SIRIUS): 1-year clinical outcomes
    Wijns, W
    Schofer, J
    Breithardt, G
    Gershlick, AH
    Garcia, E
    EUROPEAN HEART JOURNAL, 2003, 24 : 267 - 267
  • [7] Efficacy and safety at 3 and 5 years in the Canadian multicenter, randomized, double-blind trial of the sirolimus-eluting stent in the treatment of patients with de novo coronary artery lesions (C-SIRIUS)
    Schampaert, Erick
    Cohen, Eric A.
    Doucel, Michel
    Reeves, Francois
    Traboulsi, Mouhieddin
    Title, Lawrence M. Lawrence
    Neill, Blair J. O'
    Raco, Dominic
    Mehla, Shamir
    Mildenberger, Richard R.
    Plante, Sylvain
    Roy, Louis
    Bertrand, Olivier
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (8A): : 63L - 63L
  • [8] Efficacy and safety at 3 years of the sirolimus-eluting stent to treat de novo long coronary artery lesions in the Canadian multicenter, randomized, double-blind trial C-SIRIUS
    Schampaert, E
    Cohen, EA
    Palisaitis, DA
    Traboulsi, MD
    Title, LM
    O'Neill, BJ
    Raco, D
    Mildenberger, RR
    Roy, L
    Plante, S
    CIRCULATION, 2005, 112 (17) : U714 - U714
  • [9] The Canadian multicenter, randomized, double-blind trial of the sirolimus-eluting stent in the treatment of patients with de novo coronary artery lesions (C-SIRIUS): 365 day complete clinical follow-up
    Schampaert, E
    CIRCULATION, 2003, 108 (17) : 703 - 704
  • [10] Two-year outcomes after Sirolimus-Eluting Stent implantation - Results from the Sirolimus-Eluting Stent in De Novo Native Coronary Lesions (SIRIUS) trial
    Weisz, G
    Leon, MB
    Holmes, DR
    Kereiakes, DJ
    Clark, MR
    Cohen, BM
    Ellis, SG
    Coleman, P
    Hill, C
    Shi, CX
    Cutlip, DE
    Kuntz, RE
    Moses, JW
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (07) : 1350 - 1355
12345